financetom
Business
financetom
/
Business
/
Dolly Varden Silver Upsizes Bought-Deal Financing to $28 Million, Says Eric Sprott to Participate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dolly Varden Silver Upsizes Bought-Deal Financing to $28 Million, Says Eric Sprott to Participate
Aug 20, 2024 8:48 AM

11:17 AM EDT, 08/20/2024 (MT Newswires) -- Dolly Varden Silver ( DOLLF ) on Tuesday said it increased the size of its bought-deal financing by $3 million, to $28 million, and granted the underwriters a 15% over-allotment option.

The company said mining financier Eric Sprott also intends to participate in the financing.

The financing consists of 10-million shares priced at at $1.00 each, and 14.4-million flow-through shares at $1.25 each.

Proceeds from the sale of shares will be used for working capital and general corporate purposes, while proceeds from the sale of FT shares will be used to develop the Kitsault Valley project, in northwestern British Columbia.

The first tranche of the offerings is expected to close on or about September 4.

Dolly Varden shares were last seen down $0.05 to $1.03 on the TSX Venture Exchange.

Price: 1.03, Change: -0.05, Percent Change: -4.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Robinhood Shares Are Trading Higher Today: What You Need To Know
Robinhood Shares Are Trading Higher Today: What You Need To Know
Jul 15, 2024
Robinhood Markets, Inc. ( HOOD ) shares are on the rise Monday amid possible optimism ahead of Fed President Powell’s discussion and possibly as a result of investors assessing the impact of the attempted assassination of former President Trump. What To Know: Powell’s comments are anticipated to shed light on the potential timing of interest rate cuts, a key factor for...
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Jul 15, 2024
03:36 PM EDT, 07/15/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) expects a net loss of $560 million to $600 million for full year 2024, according to a regulatory filing Monday. This includes estimated non-cash stock-based compensation expenses of $70 million to $80 million. The cash, cash equivalents and marketable securities are adequate to sustain operations until 2027. The...
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Jul 15, 2024
03:39 PM EDT, 07/15/2024 (MT Newswires) -- Pulse Biosciences ( PLSE ) said Monday that it entered into an equity distribution agreement with sales agents Canaccord Genuity and Needham to sell up to $60 million in common stock from time to time. Pulse Biosciences ( PLSE ) will pay up to 3.0% of the gross sales price per share sold...
US Silica Holdings Reports Preliminary Q2 Results
US Silica Holdings Reports Preliminary Q2 Results
Jul 15, 2024
03:34 PM EDT, 07/15/2024 (MT Newswires) -- US Silica Holdings ( SLCA ) reported Monday preliminary Q2 net income of $18.7 million to $19.7 million. Two analysts polled by Capital IQ expect $18.7 million. The company reported preliminary sales of $317 million to $318 million. Two analysts surveyed by Capital IQ expect $340.3 million. Financial closing procedures for the three...
Copyright 2023-2026 - www.financetom.com All Rights Reserved